4D Molecular Therapeutics Inc
NASDAQ:FDMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
L
|
Lithium Royalty Corp
TSX:LIRC
|
CA |
|
Taskus Inc
NASDAQ:TASK
|
US |
|
Inter Parfums Inc
NASDAQ:IPAR
|
US |
|
S
|
Seagate Technology Holdings PLC
XBER:847
|
SG |
|
O'Reilly Automotive Inc
NASDAQ:ORLY
|
US |
|
K
|
Kiatnakin Phatra Bank PCL
SET:KKP
|
TH |
|
Ircon International Ltd
NSE:IRCON
|
IN |
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
US |
|
C
|
Cognizant Technology Solutions Corp
BMV:CTSH
|
US |
|
Laurentian Bank of Canada
TSX:LB
|
CA |
|
LVMH Moet Hennessy Louis Vuitton SE
F:MOH
|
FR |
|
P
|
Patterson Companies Inc
F:PD2
|
US |
|
A
|
American Express Co
XBER:AEC1
|
US |
|
Aptose Biosciences Inc
TSX:APS
|
CA |
|
R
|
Resonac Holdings Corp
XMUN:SWD
|
JP |
|
N
|
NVR Inc
F:NVE
|
US |
|
Veeco Instruments Inc
NASDAQ:VECO
|
US |
|
P
|
Procter & Gamble Co
BMV:PG
|
US |
|
Japan Hotel Reit Investment Corp
TSE:8985
|
JP |
|
Ikegps Group Ltd
NZX:IKE
|
NZ |
|
Softronic AB
STO:SOF B
|
SE |
|
Carmila SA
PAR:CARM
|
FR |
|
B
|
Braxia Scientific Corp
CNSX:BRAX
|
CA |
Wall St Price Targets
FDMT Price Targets Summary
4D Molecular Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
FDMT is 28.79 USD with a low forecast of 17.17 USD and a high forecast of 37.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FDMT's stock price target?
Price Target
28.79
USD
According to Wall Street analysts, the average 1-year price target for
FDMT is 28.79 USD with a low forecast of 17.17 USD and a high forecast of 37.8 USD.
What is the Revenue forecast for 4D Molecular Therapeutics Inc?
Projected CAGR
40%
Over the last 7 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 8 years is 40%.